318 related articles for article (PubMed ID: 32998383)
21. A novel approach to the design of inhibitors of human secreted phospholipase A2 based on native peptide inhibition.
Church WB; Inglis AS; Tseng A; Duell R; Lei PW; Bryant KJ; Scott KF
J Biol Chem; 2001 Aug; 276(35):33156-64. PubMed ID: 11427527
[TBL] [Abstract][Full Text] [Related]
22. Interference with Lipoprotein Maturation Sensitizes Methicillin-Resistant Staphylococcus aureus to Human Group IIA-Secreted Phospholipase A2 and Daptomycin.
Kuijk MM; Wu Y; van Hensbergen VP; Shanlitourk G; Payré C; Lambeau G; Man-Bovenkerk S; Herrmann J; Müller R; van Strijp JAG; Pannekoek Y; Touqui L; van Sorge NM
J Innate Immun; 2023; 15(1):333-350. PubMed ID: 36473432
[TBL] [Abstract][Full Text] [Related]
23. Secreted phospholipases A2 in cancer: diverse mechanisms of action.
Brglez V; Lambeau G; Petan T
Biochimie; 2014 Dec; 107 Pt A():114-23. PubMed ID: 25286228
[TBL] [Abstract][Full Text] [Related]
24. Streptococcal Lancefield polysaccharides are critical cell wall determinants for human Group IIA secreted phospholipase A2 to exert its bactericidal effects.
van Hensbergen VP; Movert E; de Maat V; Lüchtenborg C; Le Breton Y; Lambeau G; Payré C; Henningham A; Nizet V; van Strijp JAG; Brügger B; Carlsson F; McIver KS; van Sorge NM
PLoS Pathog; 2018 Oct; 14(10):e1007348. PubMed ID: 30321240
[TBL] [Abstract][Full Text] [Related]
25. The Roles of the Secreted Phospholipase A
Murakami M; Yamamoto K; Miki Y; Murase R; Sato H; Taketomi Y
Adv Immunol; 2016; 132():91-134. PubMed ID: 27769509
[TBL] [Abstract][Full Text] [Related]
26. Total direct chemical synthesis and biological activities of human group IIA secretory phospholipase A2.
Dong CZ; Romieu A; Mounier CM; Heymans F; Roques BP; Godfroid JJ
Biochem J; 2002 Jul; 365(Pt 2):505-11. PubMed ID: 11936952
[TBL] [Abstract][Full Text] [Related]
27. Regulatory Functions of Phospholipase A2.
Murakami M; Nakatani Y; Atsumi GI; Inoue K; Kudo I
Crit Rev Immunol; 2017; 37(2-6):127-195. PubMed ID: 29773019
[TBL] [Abstract][Full Text] [Related]
28. X-ray structure of phospholipase A2 complexed with a substrate-derived inhibitor.
Thunnissen MM; Ab E; Kalk KH; Drenth J; Dijkstra BW; Kuipers OP; Dijkman R; de Haas GH; Verheij HM
Nature; 1990 Oct; 347(6294):689-91. PubMed ID: 2215698
[TBL] [Abstract][Full Text] [Related]
29. Inhibitors of secretory phospholipase A2 group IIA.
Reid RC
Curr Med Chem; 2005; 12(25):3011-26. PubMed ID: 16378502
[TBL] [Abstract][Full Text] [Related]
30. Class specific peptide inhibitors for secretory phospholipases A2.
Mahalka AK; Kinnunen PK
Biochem Biophys Res Commun; 2013 Jun; 436(2):349-53. PubMed ID: 23747420
[TBL] [Abstract][Full Text] [Related]
31. Secretory phospholipase A₂ and airway inflammation and hyperresponsiveness.
Henderson WR
J Asthma; 2008; 45 Suppl 1():10-2. PubMed ID: 19093280
[TBL] [Abstract][Full Text] [Related]
32. Discovery of novel secretory phospholipase A2 inhibitors using virtual screen.
Qiu S; Chen F; Liu Y; Lai L
Chem Biol Drug Des; 2014 Aug; 84(2):216-22. PubMed ID: 24612767
[TBL] [Abstract][Full Text] [Related]
33. Varespladib (LY315920) and Methyl Varespladib (LY333013) Abrogate or Delay Lethality Induced by Presynaptically Acting Neurotoxic Snake Venoms.
Gutiérrez JM; Lewin MR; Williams DJ; Lomonte B
Toxins (Basel); 2020 Feb; 12(2):. PubMed ID: 32093386
[TBL] [Abstract][Full Text] [Related]
34. Lipopolysaccharide-induced release of arachidonic acid and prostaglandins in liver macrophages: regulation by Group IV cytosolic phospholipase A2, but not by Group V and Group IIA secretory phospholipase A2.
Dieter P; Kolada A; Kamionka S; Schadow A; Kaszkin M
Cell Signal; 2002 Mar; 14(3):199-204. PubMed ID: 11812647
[TBL] [Abstract][Full Text] [Related]
35. Structural aspects and activation mechanism of human secretory group IIA phospholipase.
Manukyan AK
Eur Biophys J; 2020 Sep; 49(6):511-531. PubMed ID: 32852622
[TBL] [Abstract][Full Text] [Related]
36. Polyunsaturated fatty acids potentiate interleukin-1-stimulated arachidonic acid release by cells overexpressing type IIA secretory phospholipase A2.
Kambe T; Murakami M; Kudo I
FEBS Lett; 1999 Jun; 453(1-2):81-4. PubMed ID: 10403380
[TBL] [Abstract][Full Text] [Related]
37. Phospholipase A2 is involved in the mechanism of activation of neutrophils by polychlorinated biphenyls.
Tithof PK; Schiamberg E; Peters-Golden M; Ganey PE
Environ Health Perspect; 1996 Jan; 104(1):52-8. PubMed ID: 8834862
[TBL] [Abstract][Full Text] [Related]
38. Amplification mechanisms of inflammation: paracrine stimulation of arachidonic acid mobilization by secreted phospholipase A2 is regulated by cytosolic phospholipase A2-derived hydroperoxyeicosatetraenoic acid.
Balboa MA; Pérez R; Balsinde J
J Immunol; 2003 Jul; 171(2):989-94. PubMed ID: 12847271
[TBL] [Abstract][Full Text] [Related]
39. 2-Oxoamide inhibitors of phospholipase A2 activity and cellular arachidonate release based on dipeptides and pseudodipeptides.
Barbayianni E; Stephens D; Grkovich A; Magrioti V; Hsu YH; Dolatzas P; Kalogiannidis D; Dennis EA; Kokotos G
Bioorg Med Chem; 2009 Jul; 17(13):4833-43. PubMed ID: 19443224
[TBL] [Abstract][Full Text] [Related]
40. Inhibitors of prostaglandin synthesis inhibit human prostate tumor cell invasiveness and reduce the release of matrix metalloproteinases.
Attiga FA; Fernandez PM; Weeraratna AT; Manyak MJ; Patierno SR
Cancer Res; 2000 Aug; 60(16):4629-37. PubMed ID: 10969817
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
